Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations
Cutaneous melanoma is an aggressive malignant tumor of melanocytes which accounts for 80% of skin cancer-related deaths. A number of driver mutations have been identified in melanoma, with the mutually exclusive BRAF V600E and NRAS Q61A mutations together accounting for roughly 70% of mutations. Sim...
Main Authors: | Rodney Shackelford, Maressa Pollen, Moise Vora, Tamara T. Jusion, James Cotelingam, Binu Nair |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2014-05-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/362788 |
Similar Items
-
Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma
by: Moltara Maja Ebert, et al.
Published: (2018-04-01) -
KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
by: Sergiu Pasca, et al.
Published: (2019-10-01) -
The combination of mutations in BRAF and NRAS genes within a one tumor in patients with cutaneous melanoma
by: M. B. Aksenenko, et al.
Published: (2019-10-01) -
Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
by: Aleksandra Bożyk, et al.
Published: (2021-03-01) -
Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
by: İvo Gökmen, et al.
Published: (2023-09-01)